Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Show all species
Show all synonyms
Select your species and application
anti-Human Peroxiredoxin 1 Antibodies:
anti-Mouse (Murine) Peroxiredoxin 1 Antibodies:
anti-Rat (Rattus) Peroxiredoxin 1 Antibodies:
Go to our pre-filtered search.
Human Polyclonal Peroxiredoxin 1 Primary Antibody for ICC, IF - ABIN4344918
OLeary, Terrile, Bajor, Gaj, Hennessy, Mills, Zagozdzon, OConnor, Brennan, Connor, Li, Gonzalez-Angulo, Sun, Pu, Pontén, Uhlén, Jirström, Nowis, Crown, Zagozdzon, Gallagher: Peroxiredoxin-1 protects estrogen receptor α from oxidative stress-induced suppression and is a protein biomarker of favorable prognosis in breast cancer. in Breast cancer research : BCR 2014
Show all 3 Pubmed References
Human Polyclonal Peroxiredoxin 1 Primary Antibody for IF (p), IHC (p) - ABIN750478
Sun, Zhu, Wang, Lv, Zhou, Yu, Xu, Ma, Zhong, Jia: Diagnostic and prognostic significance of peroxiredoxin 1 expression in human hepatocellular carcinoma. in Medical oncology (Northwood, London, England) 2013
Show all 2 Pubmed References
Human Monoclonal Peroxiredoxin 1 Primary Antibody for WB - ABIN2476045
Wray, Prochaska, Fisher, Shaker: Traumatic pericardial hematoma simulating tricuspid valve obstruction. in The Johns Hopkins medical journal 1976
Show all 3 Pubmed References
Human Monoclonal Peroxiredoxin 1 Primary Antibody for ELISA, WB - ABIN562097
Hirahashi, Koga, Kumagai, Aishima, Taguchi, Oda: Induced nitric oxide synthetase and peroxiredoxin expression in intramucosal poorly differentiated gastric cancer of young patients. in Pathology international 2014
Human Monoclonal Peroxiredoxin 1 Primary Antibody for ELISA, WB - ABIN450086
Araki, Kusano, Sasaki, Tanaka, Hatta, Fukui, Natsume: Redox Sensitivities of Global Cellular Cysteine Residues under Reductive and Oxidative Stress. in Journal of proteome research 2016
Human Polyclonal Peroxiredoxin 1 Primary Antibody for ELISA, WB - ABIN451613
Jönsson, Johnson, Lowther: Structure of the sulphiredoxin-peroxiredoxin complex reveals an essential repair embrace. in Nature 2008
Human Polyclonal Peroxiredoxin 1 Primary Antibody for IF (p) - ABIN912097
Szabó-Taylor, Tóth, Balogh, Sódar, Kádár, Pálóczi, Fekete, Németh, Osteikoetxea, Vukman, Holub, Pállinger, Nagy, Winyard, Buzás: Monocyte activation drives preservation of membrane thiols by promoting release of oxidised membrane moieties via extracellular vesicles. in Free radical biology & medicine 2017
The epimutation is present in three generations and results from PRDX1 mutations that force antisense transcription of MMACHC (show MMACHC Antibodies).
Peroxiredoxin I (Prx (show PRDX6 Antibodies) I) increased in tumors of hepatocellular carcinoma (HCC (show FAM126A Antibodies)) patients that aligned with overexpression of oncogenic H-ras (show HRAS Antibodies).
Prx1 might play an oncogenic role in tobacco-related oral squamous cell carcinoma and thus serve as a target for chemopreventive and therapeutic interventions.
PRDX1 safeguards telomeres from oxygen radicals to counteract telomere damage and preserve telomeric DNA for elongation by telomerase.
infection results in S-nitrosylation of multiple host proteins, including Prx1.
circulating Prdx1 provides not only prognostic information but may be a promising target against ischemia/reperfusion injury.
our findings suggest that the tumor suppressor activity of SIRT2 (show SIRT2 Antibodies) requires its ability to restrict the antioxidant activity of Prdx-1, thereby sensitizing breast cancer cells to reactive oxygen species -induced DNA damage and cell cytotoxicity
The gene signature of OPA1 (show OPA1 Antibodies), CTSA (show CTSA Antibodies), NDUFA1 (show NDUFA1 Antibodies), STK10 (show STK10 Antibodies) and PRDX1 was able to identify patients post-implant with a sensitivity of 91% and a specificity of 86% in discrimination between post-implant group and healthy controls.
UV-vis spectra of heme-PRX1 suggested that Cys52 is the axial ligand of ferric heme. PRX1 peroxidase activity was lost upon heme binding, reflecting the fact that Cys52 is not only the heme-binding site but also the active center of peroxidase activity.
Prx1 and Prx2 (show PRDX2 Antibodies) are likely targets of urate hydroperoxide in cells. Oxidation of Prxs by urate hydroperoxide might affect cell function and be partially responsible for the pro-oxidant and pro-inflammatory effects of uric acid.
This is the first report proclaiming that the ESAT-6 regulates Prdx-1 which is involved in the increase of mycobacterial uptake and survival. The intermediate mechanisms involve the increased Prdx-1 production in macrophages through the activation of p38 (show CRK Antibodies) and NRF-2 (show NFE2L2 Antibodies) dependent signaling.
in the absence of PAG, Csk becomes more associated with alternative partners; i.e., phosphatase PTPN22 and Dok adaptors. Combining PAG deficiency with PTPN22 or Dok adaptor deficiency further enhances effector T cell responses. Unlike PAG, Cbl ubiquitin ligases inhibit the activation of naive, but not of effector, T cells.
These findings suggest that extracellular Prx1-mediated TLR4 (show TLR4 Antibodies)/NF-kappaB (show NFKB1 Antibodies) pathway activation probably contributes to neuroinflammatory injury after ICH (show ACE Antibodies), and thus blocking Prx1-TLR4 (show TLR4 Antibodies) signaling might provide a novel anti-neuroinflammatory strategy with extended therapeutic window for hemorrhagic stroke
This study demonstrated that Prdx1 showed a distinct nuclear localization in the spinal cord also present in the nucleus of dorsal root ganglia (DRG) cells as well as in the sensory nerve root in embryonic development.
Prx I and Prx II appear to have a tight association with the mechanism underlying the protection of ESC stemness in developing teratomas.
Prx (show PRX Antibodies) I is an antioxidant that is up-regulated in a reactive oxygen species/p38 MAPK (show MAPK14 Antibodies)-dependent manner and governs the progression of neuroinflammation by suppressing microglial activation.
NO/SNO donors such as S-nitrosocysteine and S-nitrosoglutathione readily induced the S-nitrosylation of Prx1, causing structural and functional alterations
PrxI is not an effective protector against ozone-induced oxidative damage but plays a positive role in the initiation of lung inflammation following exposure.
Peroxiredoxin 1 stimulates endothelial cell expression of VEGF (show VEGFA Antibodies) via TLR4 (show TLR4 Antibodies) dependent activation of HIF-1alpha (show HIF1A Antibodies).
The clearance rate of Heinz body-containing RBCs in peroxiredoxin I(-/-) mice decreased significantly through the treatment of aniline hydrochloride (AH) compared with wild-type mice.
These results suggest that PRX 1 is a novel mechanosensitive antioxidant, playing an important role in shear-dependent regulation of endothelial biology and atherosclerosis.
It was assumed that Prx1 plays a leading role in X. laevis early development.
The results suggested that scarless skin-wound healing may require activation of the prx1 limb enhancer, and competence to activate the enhancer is probably a prerequisite for epimorphic regeneration, such as limb regeneration.
Data suggest a role for peroxiredoxin1 (Prdx1) in vasculature and indicating that the antioxidant function of prdx1 is important.
This gene encodes a member of the peroxiredoxin family of antioxidant enzymes, which reduce hydrogen peroxide and alkyl hydroperoxides. The encoded protein may play an antioxidant protective role in cells, and may contribute to the antiviral activity of CD8(+) T-cells. This protein may have a proliferative effect and play a role in cancer development or progression. Four transcript variants encoding the same protein have been identified for this gene.
natural killer cell-enhancing factor A
, natural killer-enhancing factor A
, proliferation-associated gene A
, proliferation-associated gene protein
, thioredoxin peroxidase 2
, thioredoxin-dependent peroxide reductase 2
, Trx dependent peroxide reductase 2
, macrophage 23 Kd stress protein
, macrophage 23 kDa stress protein
, macrophage 23kDa stress protein
, macrophase stress protein 22kDa
, macrophase stress protein 23 kd
, osteoblast specific factor 3
, osteoblast-specific factor 3
, thioredoxin dependent peroxide reductase 2
, heme-binding 23 kDa protein
, peroxiredoxin 1
, Thioredoxin peroxidase 2
, thioredoxin peroxidase II